EonArk is an AI-bio company building an artificial intelligence platform for longevity science and anti-aging drug discovery using cross-species data. The company develops interpretable machine learning systems to identify aging characteristics, model regulatory network nodes, and validate hypotheses through experimental wet-lab workflows. Additionally, EonArk offers precision health services utilizing methylation testing to assess biological age and health status as an early commercial entry point.
Subscribe to see EonArk’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EonArk is a biotechnology & ai company. Its most recent funding round, Seed, raised $14M in July 2026. Xcout tracks 7 named people at EonArk, including Si Zhao (founder and CEO).
As of 16 November 2026. Source: Xcout Intel.
1 more named person on record for EonArk, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $14M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of EonArk's closest competitors — see the full list of competitors and alternatives →
Exonic is a San Francisco-based biotechnology research company founded in 2025 that operates as an AI-native cell and gene therapeutics startup. The company utilizes artificial intelligence to design regulatory DNA and DNA sensors that adapt to complex biological contexts for adaptive medicine.
Arkangel AI is a health-tech company headquartered in Colombia that utilizes artificial intelligence to improve early disease detection and healthcare delivery. It builds predictive tools to help organizations screen and manage medical risks.
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Astromech AI Corp. is developing an autonomous biological intelligence system, termed the Large Life Model, which integrates deep learning with evolutionary biology. The platform is designed to process multi-species transcriptomic and genomic data to assist researchers in therapeutic development, trait optimization, and systems biology.
SyntekaBio, Inc. operates as an artificial intelligence and biotechnology company founded in 2009 and headquartered in Daejeon, South Korea.
Edison Scientific provides an AI platform designed for scientific research and development, specifically targeting biopharmaceutical teams. Its flagship product, Kosmos, acts as an AI scientist capable of automating scientific workflows, generating hypotheses, and analyzing data from target identification through clinical development.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about EonArk? Suggest a correction · Work at EonArk? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.